These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

613 related articles for article (PubMed ID: 15655260)

  • 1. Embryonic and adult stem cells as a source for cell therapy in Parkinson's disease.
    Levy YS; Stroomza M; Melamed E; Offen D
    J Mol Neurosci; 2004; 24(3):353-86. PubMed ID: 15655260
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Environmental cue-dependent dopaminergic neuronal differentiation and functional effect of grafted neuroepithelial stem cells in parkinsonian brain.
    Mine Y; Hayashi T; Yamada M; Okano H; Kawase T
    Neurosurgery; 2009 Oct; 65(4):741-53; discussion 753. PubMed ID: 19834380
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The homeodomain transcription factor Pitx3 facilitates differentiation of mouse embryonic stem cells into AHD2-expressing dopaminergic neurons.
    Chung S; Hedlund E; Hwang M; Kim DW; Shin BS; Hwang DY; Kang UJ; Isacson O; Kim KS
    Mol Cell Neurosci; 2005 Feb; 28(2):241-52. PubMed ID: 15691706
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cell therapy for Parkinson's disease: Functional role of the host immune response on survival and differentiation of dopaminergic neuroblasts.
    Wenker SD; Leal MC; Farías MI; Zeng X; Pitossi FJ
    Brain Res; 2016 May; 1638(Pt A):15-29. PubMed ID: 26239914
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cell transplantation in the damaged adult brain.
    Jaber M; Benoit-Marand M; Prestoz L; Gaillard A
    Rev Neurol (Paris); 2013 Nov; 169(11):838-43. PubMed ID: 24112517
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Embryonic ventral mesencephalic grafts to the substantia nigra of MPTP-treated monkeys: feasibility relevant to multiple-target grafting as a therapy for Parkinson's disease.
    Collier TJ; Sortwell CE; Elsworth JD; Taylor JR; Roth RH; Sladek JR; Redmond DE
    J Comp Neurol; 2002 Jan; 442(4):320-30. PubMed ID: 11793337
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Stem cell-based therapy for Parkinson's disease.
    Correia AS; Anisimov SV; Li JY; Brundin P
    Ann Med; 2005; 37(7):487-98. PubMed ID: 16278162
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Regulation of dopamine cell type and transmitter function in fetal and stem cell transplantation for Parkinson's disease.
    Björklund LM; Isacson O
    Prog Brain Res; 2002; 138():411-20. PubMed ID: 12432781
    [No Abstract]   [Full Text] [Related]  

  • 9. Replacing what's lost: a new era of stem cell therapy for Parkinson's disease.
    Fan Y; Winanto ; Ng SY
    Transl Neurodegener; 2020; 9():2. PubMed ID: 31911835
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Implications of Parkinson's disease pathophysiology for the development of cell replacement strategies and drug discovery in neurodegenerative diseases.
    Pan-Montojo F; Funk RH
    CNS Neurol Disord Drug Targets; 2012 Nov; 11(7):907-20. PubMed ID: 23131153
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Embryonic stem cell-derived L1 overexpressing neural aggregates enhance recovery in Parkinsonian mice.
    Cui YF; Hargus G; Xu JC; Schmid JS; Shen YQ; Glatzel M; Schachner M; Bernreuther C
    Brain; 2010 Jan; 133(Pt 1):189-204. PubMed ID: 19995872
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Stem cell treatment for Parkinson's disease: an update for 2005.
    Snyder BJ; Olanow CW
    Curr Opin Neurol; 2005 Aug; 18(4):376-85. PubMed ID: 16003112
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Stem cells in the treatment of Parkinson's disease.
    Arenas E
    Brain Res Bull; 2002 Apr; 57(6):795-808. PubMed ID: 12031276
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characterization and differentiation potential of rat ventral mesencephalic neuronal progenitor cells immortalized with SV40 large T antigen.
    Nobre A; Kalve I; Cesnulevicius K; Ragancokova D; Ratzka A; Halfer N; Wesemann M; Krampfl K; Claus P; Grothe C
    Cell Tissue Res; 2010 Apr; 340(1):29-43. PubMed ID: 20177706
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Increased cell suspension concentration augments the survival rate of grafted tyrosine hydroxylase immunoreactive neurons.
    Terpstra BT; Collier TJ; Marchionini DM; Levine ND; Paumier KL; Sortwell CE
    J Neurosci Methods; 2007 Oct; 166(1):13-9. PubMed ID: 17706789
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Survival and early functional integration of dopaminergic progenitor cells following transplantation in a rat model of Parkinson's disease.
    Hahn M; Timmer M; Nikkhah G
    J Neurosci Res; 2009 Jul; 87(9):2006-19. PubMed ID: 19235889
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neuronal cell replacement in Parkinson's disease.
    Hedlund E; Perlmann T
    J Intern Med; 2009 Oct; 266(4):358-71. PubMed ID: 19765180
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pattern of long-term sensorimotor recovery following intrastriatal and--accumbens DA micrografts in a rat model of Parkinson's disease.
    Falkenstein G; Rosenthal C; Reum T; Morgenstern R; Döbrössy M; Nikkhah G
    J Comp Neurol; 2009 Jul; 515(1):41-55. PubMed ID: 19399892
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Molecular manipulation targeting regulation of dopaminergic differentiation and proliferation of neural stem cells or pluripotent stem cells.
    Ding YX; Wei LC; Wang YZ; Cao R; Wang X; Chen LW
    CNS Neurol Disord Drug Targets; 2011 Jun; 10(4):517-28. PubMed ID: 21495963
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Axon responses of embryonic stem cell-derived dopaminergic neurons to semaphorins 3A and 3C.
    Tamariz E; Díaz-Martínez NE; Díaz NF; García-Peña CM; Velasco I; Varela-Echavarría A
    J Neurosci Res; 2010 Apr; 88(5):971-80. PubMed ID: 19859963
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 31.